Trial
NCT06390722
A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
—
Condition
Atopic Dermatitis
Intervention
Upadacitinib
Why stopped
strategic decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19